BCL2 and myocardial ischemia: These findings corroborate those of Garg et al. [91] in which AZIL increased Bcl-2 protein expression and decreased the expression of Bax and caspase-3 proteins in an in vivo model of myocardial ischemia–reperfusion injury and exerted an antiapoptotic effect.